InsiderClue
Insiders · Profile

Goeltz II Robert C.

Chief Financial Officer at Arcus Biosciences · Chief Financial Officer at CytomX Therapeutics. Filing since 20 Mar 2017. CIK 0001653881

RCUS Arcus Biosciences, Inc. Chief Financial Officer · 13 trades CTMX CytomX Therapeutics, Inc. Chief Financial Officer · 1 trade
Company
Date
Role
Action
Shares
Amount
Of holding
RCUS Arcus Biosciences, Inc.
11 May 2026
Chief Financial Officer
Sold on a plan
7,763
$198.97K
8.4%
RCUS Arcus Biosciences, Inc.
31 Dec 2025
Chief Financial Officer
Sold on a plan
6,552
$153.19K
8.8%
RCUS Arcus Biosciences, Inc.
17 Dec 2025
Chief Financial Officer
Sold on a plan
5,960
$132.07K
7.4%
RCUS Arcus Biosciences, Inc.
16 Dec 2025
Chief Financial Officer
Sold on a plan
6,702
$146.67K
7.7%
RCUS Arcus Biosciences, Inc.
26 Nov 2025
Chief Financial Officer
Sold on a plan
5,000
$125.00K
5.4%
RCUS Arcus Biosciences, Inc.
28 Oct 2025
Chief Financial Officer
Sold on a plan
5,000
$100.00K
5.1%
RCUS Arcus Biosciences, Inc.
31 Dec 2024
Chief Financial Officer
Sold on a plan
3,594
$53.91K
5.6%
RCUS Arcus Biosciences, Inc.
2 Jan 2024
Chief Financial Officer
Sold on a plan
2,004
$40.08K
3.7%
RCUS Arcus Biosciences, Inc.
7 Jun 2023
Chief Financial Officer
Sold on a plan
4,049
$81.14K
6.4%
RCUS Arcus Biosciences, Inc.
16 Dec 2022
Chief Financial Officer
Sold, plan not stated
2,453
$75.43K
17.5%
RCUS Arcus Biosciences, Inc.
17 Dec 2021
Chief Financial Officer
Sold, plan not stated
621
$25.06K
8.1%
RCUS Arcus Biosciences, Inc.
16 Dec 2021
Chief Financial Officer
Sold, plan not stated
485
$19.32K
6.0%
RCUS Arcus Biosciences, Inc.
9 Sep 2020
Chief Financial Officer
Bought
5,000
$107.85K
opened
CTMX CytomX Therapeutics, Inc.
20 Mar 2017
Chief Financial Officer
Sold, plan not stated
21,517
$426.34K
68.7%
14 decisions on file.